Stereotactic body radiotherapy and tyrosine kinase inhibitors in patients with oligometastatic renal cell carcinoma: a multi-institutional study

被引：0
|
作者：
Cem Onal
Ezgi Oymak
Ozan Cem Guler
Burak Tilki
Guler Yavas
Pervin Hurmuz
Cagdas Yavas
Gokhan Ozyigit
机构：
[1] Baskent University Faculty of Medicine,Department of Radiation Oncology, Adana Dr. Turgut Noyan Research and Treatment Center
[2] Iskenderun Gelisim Hospital,Division of Radiation Oncology
[3] Hacettepe University Faculty of Medicine,Department of Radiation Oncology
[4] Baskent University Faculty of Medicine,Department of Radiation Oncology
来源：
Strahlentherapie und Onkologie | 2023年 / 199卷
关键词：
Renal cell carcinoma; Oligometastasis; Tyrosine kinase inhibitor; Stereotactic body radiotherapy; Survival;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：456 / 464
页数：8
相关论文
共 50 条
  • [11] Stereotactic Body Radiotherapy for the Treatment of Oligometastatic Renal Cell Carcinoma
    Ranck, Mark C.
    Golden, Daniel W.
    Corbin, Kimberly S.
    Hasselle, Michael D.
    Liauw, Stanley L.
    Stadler, Walter M.
    Hahn, Olwen M.
    Weichselbaum, Ralph R.
    Salama, Joseph Kamel
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2013, 36 (06): : 589 - 595
  • [12] Recurrence pattern of stereotactic body radiotherapy in oligometastatic prostate cancer: a multi-institutional analysis
    Nicosia, Luca
    Franzese, Ciro
    Mazzola, Rosario
    Franceschini, Davide
    Rigo, Michele
    D'agostino, Giuseppe
    Corradini, Stefanie
    Alongi, Filippo
    Scorsetti, Marta
    STRAHLENTHERAPIE UND ONKOLOGIE, 2020, 196 (03) : 213 - 221
  • [13] Stereotactic radiotherapy in patients with oligometastatic or oligoprogressive gynecological malignancies: a multi-institutional analysis
    Onal, Cem
    Gultekin, Melis
    Oymak, Ezgi
    Guler, Ozan Cem
    Yilmaz, Melek Tugce
    Sari, Sezin Yuce
    Yildirim, Berna Akkus
    Yildiz, Ferah
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2020, 30 (06) : 865 - 872
  • [14] Outcomes and toxicities in oligometastatic patients treated with stereotactic body radiotherapy for adrenal gland metastases: A multi-institutional retrospective study
    Baydoun, A.
    Chen, H.
    Poon, I
    Badellino, S.
    Dagan, R.
    Erler, D.
    Foote, M. C.
    Louie, A., V
    Redmond, K. J.
    Ricardi, U.
    Sahgal, A.
    Biswas, T.
    CLINICAL AND TRANSLATIONAL RADIATION ONCOLOGY, 2022, 33 : 159 - 164
  • [15] Survival Outcomes After Adding Stereotactic Body Radiotherapy to Metastatic Renal Cell Carcinoma Patients Treated With Tyrosine Kinase Inhibitors
    He, Liru
    Liu, Yang
    Han, Hui
    Liu, Zhuowei
    Huang, Sijuan
    Cao, Wufei
    Liu, Boji
    Qin, Zike
    Guo, Shengjie
    Zhang, Zhiling
    Lin, Maosheng
    Jiang, Xiaobo
    Lin, Chengguang
    Li, Yonghong
    Yao, Kai
    Dong, Pei
    Zhou, Fangjian
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2020, 43 (01): : 58 - 63
  • [16] MANAGEMENT OF BRAIN METASTASES IN PATIENTS WITH RENAL CELL CARCINOMA IN THE ERA OF TYROSINE KINASE INHIBITORS AND STEREOTACTIC RADIOTHERAPY
    Spain, L.
    Stewart, J.
    Campbell, A.
    Lim, A.
    Joon, D. L.
    Weickhardt, A.
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2014, 10 : 42 - 42
  • [17] Stereotactic Ablative Radiotherapy for Oligometastatic Hepatocellular Carcinoma: A Multi-Institutional Retrospective Study (KROG 20-04)
    Kim, Tae Hyung
    Nam, Taek-Keun
    Yoon, Sang Min
    Kim, Tae Hyun
    Choi, Young Min
    Seong, Jinsil
    CANCERS, 2022, 14 (23)
  • [18] Treatment Outcomes of Stereotactic Body Radiotherapy in Patients with Synchronous and Metachronous Oligometastatic Renal Cell Carcinoma
    Guler, Ozan Cem
    Oymak, Ezgi
    Hurmuz, Pervin
    Yavas, Guler
    Tilki, Burak
    Yavas, Cagdas
    Ozyigit, Gokhan
    Onal, Cem
    UROLOGIA INTERNATIONALIS, 2023, 107 (02) : 171 - 178
  • [19] An international multi-institutional planning study for spine stereotactic body radiotherapy
    Hiroshi, T.
    Furuya, T.
    Naoto, S.
    Nakayama, M.
    Mark, R.
    Hao, P. Jun
    Thibault, I.
    St-Hilaire, J.
    Lijun, M.
    Pinnaduwage, D.
    Sahgal, A.
    Katsuyuki, K.
    RADIOTHERAPY AND ONCOLOGY, 2016, 119 : S926 - S926
  • [20] Multi-institutional comparison of treatment planning using stereotactic ablative body radiotherapy for hepatocellular carcinoma – benchmark for a prospective multi-institutional study
    Takahisa Eriguchi
    Atsuya Takeda
    Yohei Oku
    Satoshi Ishikura
    Tomoki Kimura
    Shuichi Ozawa
    Takeo Nakashima
    Yukinori Matsuo
    Mitsuhiro Nakamura
    Yasuo Matsumoto
    Sadanori Yamazaki
    Naoko Sanuki
    Yoshinori Ito
    Radiation Oncology, 8
12345